Weekly Recap | Sutro Biopharma +2.73%, consensus target well above spotWeekly Review·2 days ago, 12:44 AMSTRO-2.61%
Maldonado Reiterates Buy on Sutro, Sees STRO-004 Data as Proof-of-Concept and Keeps $50 Price Target UnchangedTip Ranks·Aug 12 at 12:15 PMSTRO-2.61%
12 Industrials Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Aug 12 at 12:05 PMATRO-4.17%ELOG0.00%
Sutro Biopharma shares are trading lower after the company reported worse-than-expected Q2 financial results.benzinga_article·Aug 12 at 09:19 AMSTRO-2.61%
Sutro Biopharma | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 9.839 MEarnings Watch·Aug 12 at 06:21 AMSTRO-2.61%
Sutro Biopharma (NASDAQ:STRO) Trading Down 4.8% - Time to Sell?Market Beat·Jul 9 at 02:20 PMSTRO-2.61%
Sutro Biopharma, Inc. Stock 12‑Month Price Target Raised to $43.64, Implies 14% UpsideTradingView·May 15 at 05:20 PMSTRO-2.61%FBT-0.73%
Sutro Biopharma: Buy Rating on Strong ADC Execution, Cash Runway Into 2028, and Multiple 2026 CatalystsTip Ranks·May 15 at 12:55 PMSTRO-2.61%
